Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Aug 18, 2019 12:17am

137 Views

Post# 30040366

RE:RE:RE:Cheap units could stall SP for a while

goldn1 wrote:
hanky: The way to control the most shares is to keep the shares and warrants, then buy more shares w extra cash... you have 5 years to exercise the warrants, why waste cash on them now. TLT's technology will either be successful or not successful well before warrant expiry... G1$

Sounds good. What happens to the warrants if there is a buyout?

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023